Lisanti Capital Dumps $5.4 Million Alphatec Stake as Medical Device Maker Struggles

Lisanti Capital Growth reduced its Alphatec stake by 372,407 shares, implying an estimated $5.42 million sale based on quarterly average pricing. The filing points to softer investor positioning rather than a change in company operating performance. Market impact should be limited, though the move may be read as a mild negative signal for sentiment.

Analysis

Lisanti Capital Growth reduced its Alphatec stake by 372,407 shares, implying an estimated $5.42 million sale based on quarterly average pricing. The filing points to softer investor positioning rather than a change in company operating performance. Market impact should be limited, though the move may be read as a mild negative signal for sentiment.